Adaptive mechanisms counterbalancing enhanced thrombinogenesis in antiphospholipid syndrome.
Jagellonian University, School of Medicine, Department of Medicine, Kraków, Poland.
J
J
Musiał
J
J
Swadźba
A
A
Szczeklik
D000222:Adaptation, Physiological; D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood; D016736:Antiphospholipid Syndrome / Q000097:blood* / Q000276:immunology; D000990:Antithrombin III / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D005342:Fibrinolysis; D005344:Fibrinopeptide A / Q000378:metabolism; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000276:immunology; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism; D011516:Prothrombin / Q000378:metabolism; D013917:Thrombin / Q000096:biosynthesis*; D013923:Thromboembolism / Q000517:prevention & control
D017152:Antibodies, Antiphospholipid; D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; D005344:Fibrinopeptide A; D000990:Antithrombin III; D011516:Prothrombin; D013917:Thrombin